IBD Immunology Initiative
  • Home
  • About
    • What is IBD?
    • Meet the I3 Team
    • Meet the IBD Team
    • How Can You Contribute?
    • Publications and Awards
    • Educational Opportunities
  • Our Studies
    • Observational Studies >
      • I3: IBD Immunology Initiative
      • SPARC-IBD
      • MIMIC
      • WISDOM
    • Clinical Trials >
      • URBI
      • PROMOTE IBD
      • Genetech
      • SANOFI
      • J&J
  • Current & Future Events
    • Current & Future Events
    • In the News
    • Archives >
      • Archived Events
      • Archived News
  • CORE-IBD
  • Intestinal Ultrasound
  • FAQ
    • Contact
    • Comments, Questions Concerns?
  • Donations

URBI: Utility of Random Biopsies in Patients with IBD
Defining how to best use colonoscopy to reduce colon cancer risk among patients with IBD
PIs:
Dr. James Lewis, MD
​

To learn more, visit urbistudy.org


Purpose:
​The Utility of Random Biopsies in Inflammatory Bowel Diseases Study, the URBI research study, was designed to improve how colonoscopies are performed to reduce the risk of colon cancer among patients with Crohn's Disease and Ulcerative Colitis. 

Our staff would be happy to speak to you more about the study. 

Qualifications:
  • 18 years or older 


Home
About Us
Contact Us
How Can You Contribute?
Copyright © 2020
  • Home
  • About
    • What is IBD?
    • Meet the I3 Team
    • Meet the IBD Team
    • How Can You Contribute?
    • Publications and Awards
    • Educational Opportunities
  • Our Studies
    • Observational Studies >
      • I3: IBD Immunology Initiative
      • SPARC-IBD
      • MIMIC
      • WISDOM
    • Clinical Trials >
      • URBI
      • PROMOTE IBD
      • Genetech
      • SANOFI
      • J&J
  • Current & Future Events
    • Current & Future Events
    • In the News
    • Archives >
      • Archived Events
      • Archived News
  • CORE-IBD
  • Intestinal Ultrasound
  • FAQ
    • Contact
    • Comments, Questions Concerns?
  • Donations